Showing results (41-50 of 427) with videos related to

Sort By:
Pageof 43
The Journal of Biological Chemistry|June 24, 2015
Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor SuperfamilyBryan L Roth, Wesley K Kroeze
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 25, 2008
Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settingsP Jeffrey Conn, Bryan L Roth
Idrugs : the Investigational Drugs Journal|May 21, 2005
Receptorome screening for CNS drug discoveryTimothy A Vortherms, Bryan L Roth
The International Journal of Neuropsychopharmacology|January 30, 2024
Making Sense of Psychedelics in the CNSBlake A Fordyce, Bryan L Roth
Molecular Interventions|October 13, 2006
Salvinorin A: from natural product to human therapeuticsTimothy A Vortherms, Bryan L Roth
JAMA Neurology|September 27, 2015
Chemogenetics-A Transformational and Translational PlatformJustin G English, Bryan L Roth
Schizophrenia Bulletin|July 10, 2007
Molecular targets for treating cognitive dysfunction in schizophreniaJohn A Gray, Bryan L Roth
Trends in Pharmacological Sciences|March 12, 2003
Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptorDouglas J Sheffler, Bryan L Roth
The Journal of Clinical Investigation|December 3, 2013
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugsHerbert Y Meltzer, Bryan L Roth
Brain Research|October 16, 2012
Pharmacosynthetics: Reimagining the pharmacogenetic approachMartilias S Farrell, Bryan L Roth
Pageof 43